Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Break TJ"" wg kryterium: Autor


Wyświetlanie 1-4 z 4
Tytuł:
Response to Comments on "Aberrant type 1 immunity drives susceptibility to mucosal fungal infections".
Autorzy:
Break TJ; Fungal Pathogenesis Section, Laboratory of Clinical Immunology and Microbiology (LCIM), National Institute of Allergy and Infectious Diseases (NIAID), Bethesda, MD, USA.
Oikonomou V; Fungal Pathogenesis Section, Laboratory of Clinical Immunology and Microbiology (LCIM), National Institute of Allergy and Infectious Diseases (NIAID), Bethesda, MD, USA.
Dutzan N; Oral Immunity and Inflammation Section, National Institute of Dental and Craniofacial Research (NIDCR), Bethesda, MD, USA.
Desai JV; Fungal Pathogenesis Section, Laboratory of Clinical Immunology and Microbiology (LCIM), National Institute of Allergy and Infectious Diseases (NIAID), Bethesda, MD, USA.
Swidergall M; Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, CA, USA.; David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
Freiwald T; Immunoregulation Section, Kidney Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Bethesda, MD, USA.
Chauss D; Immunoregulation Section, Kidney Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Bethesda, MD, USA.
Harrison OJ; Metaorganism Immunity Section, Laboratory of Immune System Biology, NIAID, Bethesda, MD, USA.
Alejo J; Laboratory of Pathology, Center for Cancer Research, National Cancer Institute (NCI), Bethesda, MD, USA.
Williams DW; Oral Immunity and Inflammation Section, National Institute of Dental and Craniofacial Research (NIDCR), Bethesda, MD, USA.
Pittaluga S; Laboratory of Pathology, Center for Cancer Research, National Cancer Institute (NCI), Bethesda, MD, USA.
Lee CR; Laboratory of Pathology, Center for Cancer Research, National Cancer Institute (NCI), Bethesda, MD, USA.
Bouladoux N; Metaorganism Immunity Section, Laboratory of Immune System Biology, NIAID, Bethesda, MD, USA.
Swamydas M; Fungal Pathogenesis Section, Laboratory of Clinical Immunology and Microbiology (LCIM), National Institute of Allergy and Infectious Diseases (NIAID), Bethesda, MD, USA.
Hoffman KW; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Greenwell-Wild T; Oral Immunity and Inflammation Section, National Institute of Dental and Craniofacial Research (NIDCR), Bethesda, MD, USA.
Bruno VM; Institute for Genome Sciences, University of Maryland School of Medicine, Baltimore, MD, USA.
Rosen LB; Immunopathogenesis Section, LCIM, NIAID, Bethesda, MD, USA.
Lwin W; Diabetes Center, University of California, San Francisco, CA, USA.
Renteria A; Fungal Pathogenesis Section, Laboratory of Clinical Immunology and Microbiology (LCIM), National Institute of Allergy and Infectious Diseases (NIAID), Bethesda, MD, USA.
Pontejo SM; Molecular Signaling Section, Laboratory of Molecular Immunology, NIAID, Bethesda, MD, USA.
Shannon JP; Viral Immunity and Pathogenesis Unit, LCIM, NIAID, Bethesda, MD, USA.
Myles IA; Epithelial Therapeutics Unit, LCIM, NIAID, Bethesda, MD, USA.
Olbrich P; Immunopathogenesis Section, LCIM, NIAID, Bethesda, MD, USA.
Ferré EMN; Fungal Pathogenesis Section, Laboratory of Clinical Immunology and Microbiology (LCIM), National Institute of Allergy and Infectious Diseases (NIAID), Bethesda, MD, USA.
Schmitt M; Fungal Pathogenesis Section, Laboratory of Clinical Immunology and Microbiology (LCIM), National Institute of Allergy and Infectious Diseases (NIAID), Bethesda, MD, USA.
Martin D; Genomics and Computational Biology Core, NIDCR, Bethesda, MD, USA.
Barber DL; T Lymphocyte Biology Section, Laboratory of Parasitic Diseases, NIAID, Bethesda, MD, USA.
Solis NV; Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, CA, USA.
Notarangelo LD; Immune Deficiency Genetics Section, LCIM, NIAID, Bethesda, MD, USA.
Serreze DV; The Jackson Laboratory, Bar Harbor, ME, USA.
Matsumoto M; Division of Molecular Immunology, Institute for Enzyme Research, Tokushima University, Tokushima, Japan.
Hickman HD; Epithelial Therapeutics Unit, LCIM, NIAID, Bethesda, MD, USA.
Murphy PM; Molecular Signaling Section, Laboratory of Molecular Immunology, NIAID, Bethesda, MD, USA.
Anderson MS; Diabetes Center, University of California, San Francisco, CA, USA.
Lim JK; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Holland SM; Immunopathogenesis Section, LCIM, NIAID, Bethesda, MD, USA.
Filler SG; Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, CA, USA.; David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
Afzali B; Immunoregulation Section, Kidney Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Bethesda, MD, USA.
Belkaid Y; Metaorganism Immunity Section, Laboratory of Immune System Biology, NIAID, Bethesda, MD, USA.
Moutsopoulos NM; Oral Immunity and Inflammation Section, National Institute of Dental and Craniofacial Research (NIDCR), Bethesda, MD, USA.
Lionakis MS; Fungal Pathogenesis Section, Laboratory of Clinical Immunology and Microbiology (LCIM), National Institute of Allergy and Infectious Diseases (NIAID), Bethesda, MD, USA.
Pokaż więcej
Corporate Authors:
Genomics and Computational Biology Core16
Źródło:
Science (New York, N.Y.) [Science] 2021 Sep 17; Vol. 373 (6561), pp. eabi8835. Date of Electronic Publication: 2021 Sep 16.
Typ publikacji:
Journal Article; Comment
MeSH Terms:
Immunity, Mucosal*
Mycoses*
Humans ; Mucous Membrane ; Animals ; Mice
Czasopismo naukowe
Tytuł:
Aberrant type 1 immunity drives susceptibility to mucosal fungal infections.
Autorzy:
Break TJ; Fungal Pathogenesis Section, Laboratory of Clinical Immunology and Microbiology (LCIM), National Institute of Allergy and Infectious Diseases (NIAID), Bethesda, MD, USA.
Oikonomou V; Fungal Pathogenesis Section, Laboratory of Clinical Immunology and Microbiology (LCIM), National Institute of Allergy and Infectious Diseases (NIAID), Bethesda, MD, USA.
Dutzan N; Oral Immunity and Inflammation Section, National Institute of Dental and Craniofacial Research (NIDCR), Bethesda, MD, USA.
Desai JV; Fungal Pathogenesis Section, Laboratory of Clinical Immunology and Microbiology (LCIM), National Institute of Allergy and Infectious Diseases (NIAID), Bethesda, MD, USA.
Swidergall M; Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, CA, USA.; David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
Freiwald T; Immunoregulation Section, Kidney Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Bethesda, MD, USA.
Chauss D; Immunoregulation Section, Kidney Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Bethesda, MD, USA.
Harrison OJ; Metaorganism Immunity Section, Laboratory of Immune System Biology, NIAID, Bethesda, MD, USA.
Alejo J; Laboratory of Pathology, Center for Cancer Research, National Cancer Institute (NCI), Bethesda, MD, USA.
Williams DW; Oral Immunity and Inflammation Section, National Institute of Dental and Craniofacial Research (NIDCR), Bethesda, MD, USA.
Pittaluga S; Laboratory of Pathology, Center for Cancer Research, National Cancer Institute (NCI), Bethesda, MD, USA.
Lee CR; Laboratory of Pathology, Center for Cancer Research, National Cancer Institute (NCI), Bethesda, MD, USA.
Bouladoux N; Metaorganism Immunity Section, Laboratory of Immune System Biology, NIAID, Bethesda, MD, USA.
Swamydas M; Fungal Pathogenesis Section, Laboratory of Clinical Immunology and Microbiology (LCIM), National Institute of Allergy and Infectious Diseases (NIAID), Bethesda, MD, USA.
Hoffman KW; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Greenwell-Wild T; Oral Immunity and Inflammation Section, National Institute of Dental and Craniofacial Research (NIDCR), Bethesda, MD, USA.
Bruno VM; Institute for Genome Sciences, University of Maryland School of Medicine, Baltimore, MD, USA.
Rosen LB; Immunopathogenesis Section, LCIM, NIAID, Bethesda, MD, USA.
Lwin W; Diabetes Center, University of California, San Francisco, CA, USA.
Renteria A; Fungal Pathogenesis Section, Laboratory of Clinical Immunology and Microbiology (LCIM), National Institute of Allergy and Infectious Diseases (NIAID), Bethesda, MD, USA.
Pontejo SM; Molecular Signaling Section, Laboratory of Molecular Immunology, NIAID, Bethesda, MD, USA.
Shannon JP; Viral Immunity and Pathogenesis Unit, LCIM, NIAID, Bethesda, MD, USA.
Myles IA; Epithelial Therapeutics Unit, LCIM, NIAID, Bethesda, MD, USA.
Olbrich P; Immunopathogenesis Section, LCIM, NIAID, Bethesda, MD, USA.
Ferré EMN; Fungal Pathogenesis Section, Laboratory of Clinical Immunology and Microbiology (LCIM), National Institute of Allergy and Infectious Diseases (NIAID), Bethesda, MD, USA.
Schmitt M; Fungal Pathogenesis Section, Laboratory of Clinical Immunology and Microbiology (LCIM), National Institute of Allergy and Infectious Diseases (NIAID), Bethesda, MD, USA.
Martin D; Genomics and Computational Biology Core, NIDCR, Bethesda, MD, USA.
Barber DL; T Lymphocyte Biology Section, Laboratory of Parasitic Diseases, NIAID, Bethesda, MD, USA.
Solis NV; Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, CA, USA.
Notarangelo LD; Immune Deficiency Genetics Section, LCIM, NIAID, Bethesda, MD, USA.
Serreze DV; Jackson Laboratory, Bar Harbor, ME, USA.
Matsumoto M; Division of Molecular Immunology, Institute for Enzyme Research, Tokushima University, Tokushima, Japan.
Hickman HD; Viral Immunity and Pathogenesis Unit, LCIM, NIAID, Bethesda, MD, USA.
Murphy PM; Molecular Signaling Section, Laboratory of Molecular Immunology, NIAID, Bethesda, MD, USA.
Anderson MS; Diabetes Center, University of California, San Francisco, CA, USA.
Lim JK; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Holland SM; Immunopathogenesis Section, LCIM, NIAID, Bethesda, MD, USA.
Filler SG; Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, CA, USA.; David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
Afzali B; Immunoregulation Section, Kidney Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Bethesda, MD, USA.
Belkaid Y; Metaorganism Immunity Section, Laboratory of Immune System Biology, NIAID, Bethesda, MD, USA.
Moutsopoulos NM; Oral Immunity and Inflammation Section, National Institute of Dental and Craniofacial Research (NIDCR), Bethesda, MD, USA.
Lionakis MS; Fungal Pathogenesis Section, Laboratory of Clinical Immunology and Microbiology (LCIM), National Institute of Allergy and Infectious Diseases (NIAID), Bethesda, MD, USA. .
Pokaż więcej
Corporate Authors:
Genomics and Computational Biology Core
Źródło:
Science (New York, N.Y.) [Science] 2021 Jan 15; Vol. 371 (6526).
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Candida albicans/*immunology
Candidiasis, Chronic Mucocutaneous/*genetics
Candidiasis, Chronic Mucocutaneous/*immunology
Immunity, Mucosal/*immunology
Polyendocrinopathies, Autoimmune/*genetics
Polyendocrinopathies, Autoimmune/*immunology
Adolescent ; Adult ; Aged ; Animals ; Disease Models, Animal ; Female ; Humans ; Immunity, Mucosal/genetics ; Immunologic Surveillance/genetics ; Immunologic Surveillance/immunology ; Interferon-gamma/genetics ; Interleukins/genetics ; Janus Kinases/genetics ; Male ; Mice ; Mice, Inbred BALB C ; Middle Aged ; Mouth Mucosa/immunology ; Mouth Mucosa/pathology ; Receptors, Interleukin-17/genetics ; STAT1 Transcription Factor/genetics ; T-Lymphocytes/immunology ; Young Adult ; Interleukin-22
Czasopismo naukowe
Tytuł:
Batf3-dependent CD103(+) dendritic cell accumulation is dispensable for mucosal and systemic antifungal host defense.
Autorzy:
Break TJ; a Fungal Pathogenesis Unit, Laboratory of Clinical Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health , Bethesda , MD , USA.
Hoffman KW; b Department of Microbiology , Icahn School of Medicine at Mount Sinai , New York , NY , USA.
Swamydas M; a Fungal Pathogenesis Unit, Laboratory of Clinical Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health , Bethesda , MD , USA.
Lee CC; c Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health , Bethesda , MD , USA.
Lim JK; b Department of Microbiology , Icahn School of Medicine at Mount Sinai , New York , NY , USA.
Lionakis MS; a Fungal Pathogenesis Unit, Laboratory of Clinical Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health , Bethesda , MD , USA.
Pokaż więcej
Źródło:
Virulence [Virulence] 2016 Oct 02; Vol. 7 (7), pp. 826-35. Date of Electronic Publication: 2016 May 18.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural
MeSH Terms:
Antigens, CD/*analysis
Basic-Leucine Zipper Transcription Factors/*immunology
Candidiasis, Invasive/*immunology
Candidiasis, Oral/*immunology
Dendritic Cells/*immunology
Integrin alpha Chains/*analysis
Repressor Proteins/*immunology
Animals ; Basic-Leucine Zipper Transcription Factors/genetics ; Candidiasis, Invasive/microbiology ; Candidiasis, Oral/microbiology ; Cell Proliferation ; Dendritic Cells/physiology ; Immunity, Innate ; Integrin alpha Chains/deficiency ; Interleukin-12/biosynthesis ; Interleukin-12/immunology ; Kidney/immunology ; Mice ; Mice, Inbred C57BL ; Repressor Proteins/genetics ; Tongue/immunology
Czasopismo naukowe
Tytuł:
IL-22 production is regulated by IL-23 during Listeria monocytogenes infection but is not required for bacterial clearance or tissue protection.
Autorzy:
Graham AC; Department of Molecular Biology and Immunology, University of North Texas Health Science Center, Fort Worth, Texas, United States of America.
Carr KD
Sieve AN
Indramohan M
Break TJ
Berg RE
Pokaż więcej
Źródło:
PloS one [PLoS One] 2011 Feb 15; Vol. 6 (2), pp. e17171. Date of Electronic Publication: 2011 Feb 15.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Interleukin-23/*metabolism
Interleukins/*biosynthesis
Listeria monocytogenes/*pathogenicity
Listeriosis/*metabolism
Animals ; Coinfection/immunology ; Coinfection/metabolism ; Coinfection/pathology ; Female ; Listeriosis/immunology ; Listeriosis/pathology ; Male ; Mice ; Mucous Membrane/immunology ; Mucous Membrane/metabolism ; Mucous Membrane/microbiology ; Survival Analysis ; Interleukin-22
Czasopismo naukowe
    Wyświetlanie 1-4 z 4

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies